ASHLAND, Mass., June 14 /PRNewswire/ -- MatTek Corp. today announced that EpiVaginal(TM), an innovative human cell-derived tissue model incorporating immune (dendritic) cells, for use by HIV/AIDS researchers in their investigations of HIV infection in women, has been granted a patent by the U.S. Patent Office.
